August is here and the end of summer is upon us, where does the time go?
The collection of hepatitis newsletters provided here today are brought to you by devoted advocates and organizations working hard to improve the lives of people affected by hepatitis.
Please read and review this months newsletters and consider signing up to receive an email alert for future publications, or connect on Twitter and Facebook with our valued advocates.
August Newsletters
The Hepatitis Foundation International is dedicated to liver health and the prevention of liver related diseases. We inform and educate by making available reliable and up-to-date facts. We want you to make well-informed decisions for yourself and your loved ones' health and well-being. We are proud to present this website as your personal Internet gateway to hepatitis information and liver care.
The July-August 2013 Edition of Health-e Bytes™ newsletter is now available.
Inside:
Hepatitis Foundation International Observes World Hepatitis Day
HFI in the Know...
— HFI Launches Powerful Live-R-Die© DVD
— Upcoming Viral Hepatitis Summits
— National Health Observances
Lifestyle...
— Hepatitis A, Berries and You
— "Do Not Take If..."
— Where Do Celebrities Get Their Tattoos?
— Binge Drinking = Cluster Bomb
— Heroin, Cocaine Use On the Decline?
— Obesity Threatens U.S. National Security
Grand Rounds...
— Victory for HBV Infected Medical Students
— Overactive Gene Linked to Aggressive Liver Cancer
— Psychological, lifestyle and social predictors of
hepatitis C treatment response
— Research Targets HCV’s Ability to Reproduce
In the Pipeline...
— Phase III Trials Address Advanced Liver Cancer
Helping Hands... Next year is HFI's 20th Anniversary!
Advocacy Alert: Landmark CURE Legislation
T.I.PS. — Free Healthcare Resources and Information
_______________________________________________________________
_______________________________________________________________
The HCV Advocate newsletter is a valuable resource designed to provide the hepatitis C community with monthly updates on events, clinical research, and education
August Newsletter
This Issue:
August Newsletter
This Issue:
Alan Franciscus, Editor-in-Chief
Lucinda K. Porter, RN
Jacques Chambers, CLU
Connect With HCV Advocate
_______________________________________________________________
Connect With HCV Advocate
_______________________________________________________________
_______________________________________________________________
HepCBC’s MONTHLY NEWSLETTER
The hepc.bull, has been “Canada’s hepatitis C journal” since the late 1990′s and has been published nonstop since 2001. The monthly newsletter contains the latest research results, government policy changes, activities and campaigns you can get involved in, articles by patients and caregivers, and a list of support groups plus other useful links.
Articles In This Issue Include:
HCV Activists Occupy World Health Organization!
World Hepatitis Day 2013 becomes WHD Week in BC
HepCBC and the Medical Hierarchy - An Analysis by a Medical Student
World Hepatitis Days in Nanaimo and Vancouver (great photos)
"Action Hepatitis Canada" July Meeting Update.
"Should I be Treated?" update with new research and medications
Travel Assistance Program in BC
SVR Honour Roll - people who have been 100% cured
HepCBC's "Liver Warrior" Marathon Team (October 13) and our upcoming AGM (September 10)
Conferences, Medication Assistance, Compensation
HCV Support Groups in Canada
AND MORE!!
Stay Connected
Stay Connected
_______________________________________________________________
_______________________________________________________________
Hepatitis B August Newsletters
_______________________________________________________________
_______________________________________________________________
Learn more about hepatitis B in the news by choosing from the links below:
Connect On Twitter
______________________________________________________________
______________________________________________________________
CONNECTIONS A Bimonthly e-Newsletter - July - August 2013
On June 12, HHS Assistant Secretary for Health, Dr. Howard Koh, along with CDC, launched Know Hepatitis B—a national, multilingual communication campaign to increase testing for hepatitis B among Asian Americans and Pacific Islanders (AAPIs). The campaign delivers culturally relevant messages in English, Chinese, Korean, and Vietnamese through a variety of multimedia channels. The Know Hepatitis B campaign was created and launched in partnership with Hep B United—a coalition of Asian community groups from around the country. Hep B United partners conduct community-level outreach and will incorporate campaign materials into their education about Hepatitis B. An estimated 1 in 12 AAPIs is living with hepatitis B, yet as many as 2 out of 3 people do not know they are infected.
Follow On Twitter
Follow On Twitter
_______________________________________________________________
_______________________________________________________________
2013 - Summer Newsletters
Liver, Viral Hepatitis and Transplants
_______________________________________________________________
_______________________________________________________________
This quarterly newsletter contains articles addressing all aspects of life before and after liver transplantation. Click here to sign up to receive an email when a new edition of Liver Connection is posted on our website. If you prefer to receive the newsletter by mail, you can add your name to our mailing list—or change your address, if you already receive the newsletter.
Summer 2013
Transplant News
Summer 2013
Transplant News
Volunteer of the Year
Silvia's Corner — Silvia Hafliger, MD
Transplant Readiness Part I: Are you prepared for the lifelong journey?
Patient Voices: A Reflection
Caregiving: The Nuts and Bolts of Caregiving
The Pharmacy Corner — Use of Herbal Products After Transplantation
Pediatric News
Staying in Touch
Educational Workshops
Transplant Support Groups
Transplant Resources
Area Support Groups
Visit Us On
_______________________________________________________________
Visit Us On
_______________________________________________________________
_______________________________________________________________
In the Summer 2013 issue, Congressman Hank Johnson talks about being cured of his hep C.
Current Issue - Click here to read a digital version of this issue.
Current Issue - Click here to read a digital version of this issue.
by Oriol R. Gutierrez Jr.
More than 3 million people are living with hepatitis C in the United States—and most of them aren't aware of their status. The only way to know if you have hep C is to get tested
by Benjamin Ryan
Cured of his hepatitis C, he now fights for Americans with viral hepatitis.
by Benjamin Ryan
Hepatitis C is a virus that can result in serious liver damage, including cirrhosis (scarring of the liver), liver cancer and possibly death. There is no vaccine for the hep C virus (HCV), but there are treatments that can cure the virus in some people.
by Benjamin Ryan
Those who receive optimal pre-treatment care are much more likely to undergo and complete antiviral treatment for hep C.
by Benjamin Ryan
A report from the Economist Intelligence Unit outlines the inadequate governmental response to the viral hepatitis epidemic around the globe and urges major action to address the escalating medical and economic impact of the virus.
by Benjamin Ryan
Hepatitis C treatment appears to cut in half the rates of liver cancer among those with fibrosis or cirrhosis (scarring of the liver), according to a Danish study.
by Benjamin Ryan
Using syringes designed to have less “dead space”—meaning, they retain a smaller amount of fluid after the plunger has been depressed—may help prevent HIV and hepatitis C transmission among injection drug users.
by Benjamin Ryan
As the baby boomers age, the United States will see a peak and then significant tapering of hep C cases, liver disease and associated health care costs in the next two decades.
Even Moderate Drinking Raises Risk of Death
by Benjamin Ryan
Having even one drink a day can significantly raise your risk of death if you’re living with hepatitis C.
Join Us
_______________________________________________________________
Gastroenterology & Endoscopy News
From EASL and DDW 2013
Experts' Picks: Top Liver Abstracts
Three expert hepatologists share their opinions of the top liver abstracts:
A Few Abstracts Include:
Sofosbuvir + Peginterferon + Ribavirin for 12 Weeks Achieves 90% SVR12 in Genotype 1, 4, 5, or 6
All Oral Therapy With Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced GT2/3
All-Oral Sofosbuvir-Based 12-Wk Regimens: The ELECTRON Study
Safety and Efficacy of Interferon-Free Regimens of ABT-450/R, ABT-267, ABT-333 ± Ribavirin
View All Top Picks .....
Stay connected
_______________________________________________________________
GI & Hepatology News
GI & Hepatology News is the official newspaper of the AGA Institute and provides the gastroenterologist with timely and relevant news and commentary about clinical developments and about the impact of health-care policy. The newspaper is led by an internationally renowned board of editors.
View Current Issue (VOL. 7 NO. 8 AUGUST 2013):
PDF | Interactive Version
DDW 2013
GI & Hepatology News
DDW 2013 The AGA Report
Download PDF | Digital Edition
Gain insights from the perspectives of Dr. Colin W. Howden, GI & Hepatology News Editor-in-Chief, and invited experts on the top studies reported at Digestive Disease Week® 2013.
Topics In Liver Disease Include
Simeprevir does well in QUEST-2 and PROMISE phase III studies
Nosocomial infection in cirrhotic patients boosts acute kidney injury risk
Telaprevir-based triple-drug therapy benefits CHC patients with ESRD
After HCV treatment failure, some success with boceprevir-IFN-ribavirin
Connect With AGA
_______________________________________________________________
Even Moderate Drinking Raises Risk of Death
by Benjamin Ryan
Having even one drink a day can significantly raise your risk of death if you’re living with hepatitis C.
Join Us
_______________________________________________________________
_______________________________________________________________
Gastroenterology & Endoscopy News
From EASL and DDW 2013
Experts' Picks: Top Liver Abstracts
Three expert hepatologists share their opinions of the top liver abstracts:
A Few Abstracts Include:
Sofosbuvir + Peginterferon + Ribavirin for 12 Weeks Achieves 90% SVR12 in Genotype 1, 4, 5, or 6
All Oral Therapy With Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced GT2/3
All-Oral Sofosbuvir-Based 12-Wk Regimens: The ELECTRON Study
Safety and Efficacy of Interferon-Free Regimens of ABT-450/R, ABT-267, ABT-333 ± Ribavirin
View All Top Picks .....
Stay connected
_______________________________________________________________
_______________________________________________________________
GI & Hepatology News
GI & Hepatology News is the official newspaper of the AGA Institute and provides the gastroenterologist with timely and relevant news and commentary about clinical developments and about the impact of health-care policy. The newspaper is led by an internationally renowned board of editors.
View Current Issue (VOL. 7 NO. 8 AUGUST 2013):
PDF | Interactive Version
DDW 2013
GI & Hepatology News
DDW 2013 The AGA Report
Download PDF | Digital Edition
Gain insights from the perspectives of Dr. Colin W. Howden, GI & Hepatology News Editor-in-Chief, and invited experts on the top studies reported at Digestive Disease Week® 2013.
Topics In Liver Disease Include
Simeprevir does well in QUEST-2 and PROMISE phase III studies
Nosocomial infection in cirrhotic patients boosts acute kidney injury risk
Telaprevir-based triple-drug therapy benefits CHC patients with ESRD
After HCV treatment failure, some success with boceprevir-IFN-ribavirin
Connect With AGA
_______________________________________________________________
_______________________________________________________________
NYC Viral Hepatitis Monthly E-Newsletter
06/10/2013 - Summer 2013 NYC Hep ABC Newsletter
Join Us
_______________________________________________________________
July Newsletters
Join Us
_______________________________________________________________
_______________________________________________________________
______________________________________________________________
_______________________________________________________________
Hep Chat is Hepatitis Victoria's electronic newsletter that is published 8 times a year
View our latest Hep Chat newsletter here - July 2013 Edition
Hepatitis C Treatment Outcome Study - Call for Survey Participants
Hepatitis C Treatment Outcome Study - Call for Survey Participants
Are you about to undertake Hepatitis C treatment?
The Bond University in Queensland is looking for individuals over 18 to complete their survey as part of a The Hepatitis C Treatment Outcome Study.
Participants are being sought from within Australia or from other countries.
The study is designed to determine some of the physical, psychological, and social factors associated with Hepatitis C treatment outcomes.
The primary objective of this research is to increase understanding of individual profiles that are associated with better Hepatitis C treatment outcomes.
The primary objective of this research is to increase understanding of individual profiles that are associated with better Hepatitis C treatment outcomes.
The first survey must be completed prior to the commencement of treatment and the second at a designated milestone during treatment. The first survey should take 35-40 minutes to complete, whilst the second survey can be completed in 5-10 minutes.
Information provided is completely confidential and you have the right to withdraw from the study at any time.
For more information on the study or to participate visit http://hepcstudy.hsstechnology.bond.edu.au
Connect With Us
Connect With Us
_______________________________________________________________
_______________________________________________________________
Our newsletter is sent out for free electronically on the 1st of every month.
To subscribe, please send your email address to slh@hepc-connection.org.
July 2013
To subscribe, please send your email address to slh@hepc-connection.org.
July 2013
*Check Back With Hep C Connections For Their August Publication
Find Hep C Connections On Facebook
_______________________________________________________________
_______________________________________________________________
Research
_______________________________________________________________
_______________________________________________________________
Hepatitis C Choices
5th edition Free Online Book
_______________________________________________________________
_______________________________________________________________
_______________________________________________________________
_______________________________________________________________
No comments:
Post a Comment